Meniscal Lesions in Return to Sport After Anterior Cruciate Ligament Reconstruction

NCT04129827 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2021-10-08

No results posted yet for this study

Summary

Most athletes who undergo Anterior Cruciate Ligament Reconstruction (ACLR) plan to return to some level of sporting (RTS) activity. However, rates of return to pre-injury sport are often less than might be expected and many factors influence whether individuals return to sport after this surgery. This study aims to better understand the role of meniscal lesions in RTS and to assess the advantage of the integrated evaluation with clinical, biomechanical and psychological tests to decide the correct RTS timing in non-professional athletes undergoing ACLR.

Conditions

  • ACL Injury
  • Meniscus Lesion
  • Sport Injury

Interventions

OTHER

Clinical, self-reported psychological and biomechanical assessments

1. medical check up * active and passive Range Of Motion (ROM) * anterior drawer test * knee's alignment * modified cincinnati rating system questionnaire (mCRSQ) * tegner lysholm knee scoring scale (TLKS) * Tegner Activity Level Score (TALS) 2. self-reported psychological questionnaires * Tampa Scale of Kinesiophobia (TSK) * ACL Return to Sport after Injury (ACL-RSI) score 3. biomechanical tests * Stability test: to balance on one/two legs on a free to move disc for 30s * Jump test: i) a maximize jump with both legs; ii) a maximize jump with only one leg; three consecutive jumps; iv) jump coordination path where the patient had to perform a forward-backward-forward jump and a sideway jump on one leg * Coordination test: a square hurdle was used for the quick test, where the patient had to step in and out with both feet for a total of 15-rep as quickly as possible * fatigue test: to rise and sit from a chair for 30-rep as quickly and safely as possible

Sponsors & Collaborators

  • Istituto di Fisiologia Clinica CNR

    collaborator OTHER
  • University of Bari

    lead OTHER

Principal Investigators

  • Lorenzo Moretti, MD · Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2018-12-21
Completion
2019-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04129827 on ClinicalTrials.gov